In the last decade, growing evidence has indicated that CD4+ T cells can contribute to control tumor growth in humans [130–134], and CD4+ T cells specific for neo-antigens have been detected within tumors with elevated Tumor Mutational Burden, such as melanoma [132]. This evidence concerns the gene CD4 and melanoma.